Novartis agrees to pay $390m in US kickback caseBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5784 (Published 28 October 2015) Cite this as: BMJ 2015;351:h5784
- Michael McCarthy
Novartis AG, the Swiss drug company, has agreed to pay $390m (£255m; €352m) to settle a lawsuit in which the US government claimed that the company had paid kickbacks to specialty pharmacies to boost sales of its drugs.
The lawsuit filed by the US Department of Justice had initially sought $3.35bn in fines and damages, charging that the kickback …
Log in using your username and password
Log in through your institution
Sign up for a free trial